Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G inhibitory and G o proteins (Gi/o) are a major subfamily of heterotrimeric G proteins that act as critical intracellular transducers downstream of G protein-coupled receptors (GPCRs). Upon activation by GPCRs, Gi/o proteins dissociate into Gαi/o and Gβγ subunits, which inhibit adenylyl cyclase to decrease intracellular cyclic AMP (cAMP) levels and modulate various effectors, including G protein-coupled inwardly rectifying potassium (GIRK) channels and voltage-gated calcium channels. These proteins play essential roles in regulating neuronal excitability, heart rate, and hormone secretion. Dysregulation of Gi/o protein signaling is implicated in several diseases, including cancer progression, chronic pain, neurodegenerative disorders, and movement disorders such as GNAO1 encephalopathies. Pharmacological modulation of Gi/o proteins can be achieved directly using tools like pertussis toxin, which inactivates them via ADP-ribosylation, or mastoparan, which directly activates them. Developing selective small-molecule inhibitors of Gi/o proteins represents a promising therapeutic strategy to overcome GPCR redundancy in cancer and treat rare genetic encephalopathies.
ADP-ribosylation and inactivation of Gi/o proteins, direct receptor-independent activation of Gi/o proteins, inhibition of Gβγ subunit signaling, competitive inhibition of Gαi protein-protein interactions, or inhibition of GTP binding and nucleotide exchange.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G inhibitory and G o proteins (Gi/o).